Stock Analysis: Strides Arcolab, Dabur India
SI Reporter/Mumbai 01 Feb 12 | 09:41 AM
Read in-depth analysis here before investing your hard earned money.
It is not surprising that Strides Arcolab’s stock has risen sharply after the company announced stake sale in its low-margin subsidiary, Ascent Pharma. After this news, in just five trading sessions, the stock has risen 29 per cent to Rs 526 — its all-time high. Click here for more
Over the last one year, when valuations of consumer stocks have commanded a premium, Dabur has underperformed both peers and the broader market. In Q2, most categories, except haircare, saw single-digit growth. But, double-digit growth seems to have returned in Q3. Click here for more
Related Stories
-
No Related Stories Found
Read Other Stories
advertisements
Most Popular
Sensex
| Company | Price | Gain (%) |
|---|---|---|
| GAIL (India) | 336.30 | 3.37 |
| Tata Steel | 408.25 | 2.43 |
| DLF | 188.45 | 1.89 |
| St Bk of India | 2,005.00 | 1.74 |
| Larsen & Toubro | 1,186.40 | 1.54 |

Leave a reply
(Max. 1000 characters)